Sinopharm Group Co.-Unsp ADRSHTDY
13F holders, Q2 2024 (June 30)3holders
0new positions
0sold out
$13.23avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Sinopharm Group Co.-Unsp ADR (SHTDY) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($15K), GAMMA Investing LLC ($4K) and PNC Financial Services Group, Inc. ($3K).
- Company
- Sinopharm Group Co.-Unsp ADR
- CUSIP
- 82937K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 463 shares bought and 15 shares sold, net +448 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | Add +72.6% | 1,101 | $15K |
| GAMMA Investing LLC | 0.00% | No change | 313 | $4K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -6.4% | 221 | $3K |
"% of holder's portfolio" is SHTDY's weight in each manager's 13F, not the share of Sinopharm Group Co.-Unsp ADR the manager owns.